Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / MYL - Better Buy: Pfizer vs. Merck


MYL - Better Buy: Pfizer vs. Merck

Pfizer (NYSE: PFE) and Merck (NYSE: MRK) are both multinational pharmaceutical heavyweights, complete with massive development pipelines, numerous subsidiaries, and consistently profitable operations. With nearly identical market caps in the $200 billion range, Merck and Pfizer appear to be two of the most evenly matched competitors in the pharmaceutical sector. 

So, how should potential investors choose between these two seemingly similar stocks? Let's examine the merits of each more closely.

Image Source: Getty Images.

Continue reading

Stock Information

Company Name: Mylan N.V.
Stock Symbol: MYL
Market: NASDAQ
Website: viatris.com

Menu

MYL MYL Quote MYL Short MYL News MYL Articles MYL Message Board
Get MYL Alerts

News, Short Squeeze, Breakout and More Instantly...